Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06793995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trial| NCT Number | NCT06793995 |
| Lead Sponsor | Luye Pharma Group Ltd. |
| Conditions | Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia |
| Enrollment | 26 participants |
| Start Date | 2025-02 |
| Primary Completion | 2025-10-31 (estimated) |
| Study Completion | 2025-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-01-27 |